Miran Šebeštjen

17PUBLICATIONS
28CO-AUTHORS
Regenerative medicine (incl. stem cells)Respiratory diseasesCardiology (incl. cardiovascular diseases)Medical biochemistry - proteins and peptides (incl. medical proteomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 27, 2025
SGLT2 Inhibitors Are Associated with Left Ventricular Reverse Remodeling in Patients with Non-Compaction Cardiomyopathy-A Prospective Observational Cohort Trial.

Andraž Cerar, Gregor Poglajen, Gregor Zemljič

|Sep 26, 2025
Renal Response to Levosimendan in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation Predicts Early Postoperative Renal Function Course.

Gregor Zemljic, Gregor Poglajen, Sabina Frljak

|Feb 26, 2025
Effect of PCSK9 Inhibitors on Regulators of Lipoprotein Homeostasis, Inflammation and Coagulation.

Patricija Lunar, Hana Meglič, Mateja Vehar

|Jan 23, 2024
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values.

Sabina Ugovšek, Andreja Rehberger Likozar, Tina Levstek

|Oct 28, 2023
Smoking and Diabetes Attenuate Number of CD34+ Haematopoietic Stem Cells in Peripheral Blood of Patients with Advanced Peripheral Artery Disease.

Barbara Sernek, Rok Kamnikar, Miran Sebestjen

|Mar 29, 2023
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors.

Tina Levstek, Tina Karun, Andreja Rehberger Likozar

Pageof 3

Frequent Collaborators

6 joint publications

Andreja Rehberger Likozar

4 joint publications

Gregor Poglajen

4 joint publications

Katarina Trebušak Podkrajšek

4 joint publications

Sabina Ugovšek